Single-Shot hope for bowel disease tested in early trial
Disease control
Terminated
This early-stage study tested a new drug called BB-TL1A-VIAL-HLE to see if it is safe and might help people with moderate-to-severe ulcerative colitis. The trial involved 16 healthy volunteers and people with the condition, who received a single injection. Researchers monitored p…
Phase: PHASE1 • Sponsor: Vial Australia Pty Ltd • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC